Patent applications EP07789150.5 and EP03748286.6 will be allowed to grant by the European Patent Office, thus further strengthening Nanomerics’ patent portfolio and its business activities in the European Union. These two patents directly underpin Nanomerics’ key drug delivery technology - Nanomerics’ MET.
Nanomerics today announced the receipt of news that two key patents on its Molecular Envelope Technology (MET) will be granted by the European Patent Office.
Nanomerics continues to fortify its patent estate by filing and licensing additional intellectual property. “I am delighted that the European Patent Office has seen fit to allow these two applications to proceed to grant, as these applications, once granted, will enable us to strike lucrative licensing deals for the products we are developing with Nanomerics’ MET”, says Professor Andreas G. Schatzlein, Nanomerics’ Chief Executive Officer.